Novavax expands Sanofi license for Matrix-M adjuvant use
Go back to Novavax expands Sanofi license for Matrix-M adjuvant use| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.46 -0.37 (4.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.83 | 52 Week High | $9.23 | |||
| Open | $7.90 | 52 Week Low | $1.16 | |||
| Day High | $7.93 | P/E | N/A | |||
| Day Low | $7.45 | EPS | $-0.30 | |||
| Volume | 3,178,148 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.35 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.36 | 52 Week High | $44.76 | |||
| Open | $43.16 | 52 Week Low | $36.81 | |||
| Day High | $43.49 | P/E | N/A | |||
| Day Low | $42.94 | EPS | $0.00 | |||
| Volume | 3,067,633 | |||||

